BeStock  
Stocks › Biotechnology › AVLN

Avalyn Pharma AVLN

US equityMarket cap rank #3002Biotechnology
$28.40 −$0.30 (-1.05%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.40 0.00%
Open$28.06
Prev close$28.70
Day range$27.85 – $29.38
Volume214.3K
Market cap$1.26B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts1
Average target$60.00+111.3% vs. price
  • Buy 100%

Recent rating changes

The last 8 actions on file set price targets from $51.00 to $60.00, averaging $53.75.

DateFirmRatingTarget
2 Oct 2026 Raymond James BUY $60.00
13 Aug 2026 Morgan Stanley BUY $57.00
13 Aug 2026 Jefferies BUY $52.00
3 Jun 2026 Morgan Stanley BUY $53.00
26 May 2026 Morgan Stanley BUY $53.00
26 May 2026 Jefferies BUY $52.00
26 May 2026 Evercore BUY $51.00
25 May 2026 Jefferies BUY $52.00

Discussion

No comments yet — be the first to weigh in on AVLN.

Sign in to join the discussion.

Scroll to Top